Otolith developed this therapeutic device in partnership with patients, scientists and clinicians over multiple years. Through this process, the device has been studied on hundreds of participants with no serious device related adverse events. User feedback including materials, comfort, and preference has been captured in our design process. From this pursuit of evidence, Otolith is seeking FDA marketing approval in the De Novo pathway as a novel, prescription device fit for inclusion in daily life.